This pharma stock rose over 40% amid pandemic, ICICI Direct sees more upside still
Updated : July 20, 2020 05:57 PM IST
Pharma company Cipla has outperformed benchmarks and pharma index in the year 2020 on a year-to-date basis
In a recent report, ICICI Direct suggested another 15 percent upside for the stock.
It is also one of the 6 stocks that have received earnings upgrade from brokerage CLSA for FY22.